Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Ofokansi KC, Attama AA, Uzor PF and Ovri MO
Infectious diseases caused by multi-resistant strains of Staphylococcus aureus are on the increase and fighting them with natural products may be more efficacious. The aim of this study was to investigate the in vitro antibacterial activity of methanol leaf extract and the solvent fractions of Phyllanthus muellerianus (Kuntze) Excell as well as their combinations with ciprofloxacin against various isolates of Staphylococcus aureus. Phytochemical screening was done following established method while the in vitro antimicrobial properties of the extract and fractions of the extract were investigated by the agar diffusion method. Agar diffusion Checkerboard and Overlay Inoculum susceptibility disc methods were further employed to study the interaction of the extract, fraction and ciprofloxacin against eight (8) isolates of S. aureus. Results showed that the extract and the fractions contain glycosides, flavonoids, saponins and alkaloids. N- Hexane and methylene chloride fractions showed no activity against the test microorganisms, while methanol fraction and methanol crude extract produced a concentration dependent antibacterial activity against the organisms. Result of interaction study revealed synergism in some of the combination ratios but the predominant effects were indifference and antagonism. The study has demonstrated that the leaf extract and the polar fraction of the plant, P. muellerianus, possess potent antibacterial effect against various strains of S. aureus. Combination of the extract or the fraction with ciprofloxacin could be beneficial in treating infections caused by S. aureus.